Unknown

Dataset Information

0

Understanding LAG-3 Signaling.


ABSTRACT: Lymphocyte activation gene 3 (LAG-3) is a cell surface inhibitory receptor with multiple biological activities over T cell activation and effector functions. LAG-3 plays a regulatory role in immunity and emerged some time ago as an inhibitory immune checkpoint molecule comparable to PD-1 and CTLA-4 and a potential target for enhancing anti-cancer immune responses. LAG-3 is the third inhibitory receptor to be exploited in human anti-cancer immunotherapies, and it is considered a potential next-generation cancer immunotherapy target in human therapy, right next to PD-1 and CTLA-4. Unlike PD-1 and CTLA-4, the exact mechanisms of action of LAG-3 and its relationship with other immune checkpoint molecules remain poorly understood. This is partly caused by the presence of non-conventional signaling motifs in its intracellular domain that are different from other conventional immunoregulatory signaling motifs but with similar inhibitory activities. Here we summarize the current understanding of LAG-3 signaling and its role in LAG-3 functions, from its mechanisms of action to clinical applications.

SUBMITTER: Chocarro L 

PROVIDER: S-EPMC8156499 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4261025 | biostudies-literature
2022-05-17 | GSE99114 | GEO
| S-EPMC8130412 | biostudies-literature
| S-EPMC4098103 | biostudies-literature
| S-EPMC11319776 | biostudies-literature
| S-EPMC2691990 | biostudies-literature
| S-EPMC2849049 | biostudies-literature
2022-05-17 | GSE99115 | GEO
| S-EPMC5573916 | biostudies-literature
| S-EPMC8772252 | biostudies-literature